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ON THE VANISHING VISCOSITY APPROXIMATION OF
A NONLINEAR MODEL FOR TUMOR GROWTH
DONATELLA DONATELLI AND KONSTANTINA TRIVISA
Abstract. We investigate the dynamics of a nonlinear system mod-
eling tumor growth with drug application. The tumor is viewed as a
mixture consisting of proliferating, quiescent and dead cells as well as a
nutrient in the presence of a drug. The system is given by a multi-phase
flow model: the densities of the different cells are governed by a set of
transport equations, the density of the nutrient and the density of the
drug are governed by rather general diffusion equations, while the veloc-
ity of the tumor is given by Darcy’s equation. The domain occupied by
the tumor in this setting is a growing continuum Ω with boundary ∂Ω
both of which evolve in time. Global-in-time weak solutions are obtained
using an approach based on the vanishing viscosity of the Brinkman’s
regularization. Both the solutions and the domain are rather general,
no symmetry assumption is required and the result holds for large initial
data.
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2 DONATELLI AND TRIVISA
1. Introduction
1.1. Motivation. In recent years, there has been an increased interest in
the mathematical modeling and numerical simulation of tumor growth to
complement experimental and clinical studies and thereby improve the un-
derstanding of cancer progression. Mathematical models describing contin-
uum cell populations and their development typically consider the interac-
tions between the cell number densities and one or more chemical species
that provide nutrients and drug or influence the cell cycle events of a tumor
cell population.
In this work we investigate the dynamics of a nonlinear system describing
the evolution of cancerous cells. The tumor is viewed as a multiphase flow
consisting of proliferating cells, quiescent cells and dead cells (also known as
extra-cellular cells) in the presence of a nutrient (oxygen) and drug. Here,
and in what follows, we denote by P,Q and D the densities of proliferating,
quiescent and dead cells respectively, and by C and W the nutrient and drug
concentrations.
The mathematical model under consideration is governed by a system of
transport equations for the evolution of cancerous cells; two rather general
diffusion equations which are used to describe the diffusion of the nutri-
ent (oxygen) within the tumor region and the evolution of the drug within
the same regime and the Darcy law, which determines the velocity field.
The continuous movement within the tumor region is due to proliferation,
mitosis, apoptosis or removal of cells.
1.2. Biological principles. Our model is based on the following biological
principles (cf. Roda et al. [11, 12], Friedman et al. [8], [9], Zhao [17]):
• Living cells are either in a proliferating phase or in a quiescent phase.
• Proliferating cells die as a result of apoptosis, which is a cell-loss mech-
anism. Quiescent cells die in part due to apoptosis and more often due
to starvation. In fact the proliferation and the necrotic death rates of
tumor cells depend on the oxygen level.
• The dead tumor cells are obtained from necrosis and apoptosis of live
tumor cells, and they are cleared by macrophages.
• Living cells undergo mitosis, a process that takes place in the nucleus
of a dividing cell.
• Cells change from quiescent phase into proliferating phase at a rate
which increases with the nutrient level, and they die at a rate which
increases as the level of nutrient (oxygen) decreases.
• Proliferating cells become quiescent and die at a rate which increases as
the nutrient concentration decreases. The proliferation rate increases
with the nutrient concentration.
• Proliferating cells and quiescent cells become dead cells at a rate which
depends on the drug concentration.
We denote by Ωt := Ω(t) the tumor region and its boundary ∂Ωt evolves
with respect to time. Both live and dead tumor cells are assumed to be
in the tumor region Ωt. Abnormal proliferation of tumor cells generates
internal pressure in Ω(t), resulting to a velocity field v 6= 0.
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1.3. Governing equations of cells, oxygen and drug.
1.3.1. Transport equations for the evolution of the cell densities. All the cells
are assumed to follow the general continuity equation:
∂n
∂t
+ divx(nv) = G(n),
where n may represent densities of proliferating/quiescent and dead cells.
The function G includes in general proliferation, apoptosis or clearance of
cells, and chemotaxis terms as appropriate.
The change of phase of the cancerous cells generates a continuous move-
ment within the tumor represented by a velocity field v.
The rates of change from one phase to another are functions of the nutrient
concentration C.
• KQ(C) denotes the rate of change of phase from P → Q;
• KP (C) denotes the rate of change from Q→ P ; while
• KA(C) and KD(C) denote the change of phases from P → D and
Q→ D respectively.
Here, KA stands for apoptosis, whereas dead cells are removed at rate KR
(independent of C), and the rate of cell proliferation (new births) is KB.
1.3.2. The tumor tissue as a porous medium. Due to proliferation and re-
moval of cells there is continuous motion of cells within the tumor; this
movement is represented by the velocity field v given by the Darcy’s equa-
tion
∇xσ = − µ˜
K
v. (1.1)
where σ denotes the pressure, µ˜ is a positive constant describing the viscous
like properties of tumor cells, whereas K denotes the permeability. In the
present context, (1.1) accounts for the friction of the tumor cells with the
extracellular matrix
The mass conservation laws for the densities of the proliferative cells P,
quiescent cells Q and dead cells D in Ω(t) take the following form:
∂P
∂t
+ div(Pv) = GP , (1.2)
∂Q
∂t
+ div(Qv) = GQ, (1.3)
∂D
∂t
+ div(Dv) = GD. (1.4)
Following Friedman [8], the source terms {GP,GQ,GD} are of the following
form:
GP =
(
KBC −KQ(C¯ − C)−KA(C¯ − C)
)
P +KPCQ− i1G1(W )P, (1.5)
where G1(·) a smooth function and KB, KQ, KA are positive constants.
The first term in this equation accounts for the increase of the number of
cells due to new births, loss due to change of phase from proliferating to
quiescent and loss due to apoptosis. The second term reflects the increase
of the number of proliferating cells generated from quiescent cells, whereas
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the third term accounts for the decrease of the number of cells due to death
resulting from the effect of drug. In an analogous fashion
GQ = KQ(C¯ − C)P −
(
KPC +KD(C¯ − C)
)
Q− i2G2(W )Q, (1.6)
with G2(·) a smooth function and KP , KQ, KD positive constants. In the
above relations (1.5)-(1.6) i1G1(W ) and i2G2(W ) denote the rates by which
the proliferating cells and the quiescent cells become dead cells due to the
drug. Finally,
GD = KA(C¯−C)P+KD(C¯−C)Q−KRD+i1G1(W )P+i2G2(W )Q. (1.7)
1.3.3. A linear diffusion equation for the evolution of nutrient. Tumor cells
consume nutrients (oxygen). In contrast to the equations of cell densities,
the equations of the oxygen molecules in the tumor include diffusion terms
in the following form:
∂C
∂t
= ∇ · (ν1∇C)−
(
K1KPCP +K2KQ(C¯ − C)Q
)
C.
Assuming that ν1 is constant this equation (cf. Friedman [8]) becomes
∂C
∂t
= ν1∆C −
(
K1KPCP +K2KQ(C¯ − C)Q
)
C. (1.8)
This equation describes the diffusion of the oxygen in the tumor region.
According to (cf. Ward and King [15], [16]) the nutrient is consumed at a
rate proportional to the rate of cell mitosis, namely the second term on the
right-hand side of the first equation in (1.8).
1.3.4. A linear diffusion equation for the evolution of drug. The evolution
of the drug concentration in the tumor is given by a diffusion equation of
the form
∂W
∂t
= ∇ · (ν2∇W )− (µ1G1(W )P + µ2G2(W )Q)W,
with G1(·), G2(·) smooth functions.
Assuming that ν2 is constant this equation (cf. Zhao [17]) becomes
∂W
∂t
= ν2∆W − (µ1G1(W )P + µ2G2(W )Q)W. (1.9)
This equation describes the diffusion of the drug within the tumor region.
The second term of the right-hand side of (1.9) represents the drug consump-
tion, the constants µ1, µ2 are two positive constants which can be viewed as
a measure of the drug effectiveness.
The total density of the mixture is denoted by %f and is given by
%f = P +Q+D = Constant. (1.10)
Adding (1.2)-(1.4) and taking into consideration (1.10) we arrive at the
following relation, which represents an additional constraint
ρf div v = GP +GQ +GD = KBCP −KRD. (1.11)
Our aim is to study the system (1.1)-(1.11) in a spatial domain Ωt, with
a boundary Γ = ∂Ωt varying in time.
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1.3.5. Boundary behavior. The boundary of the domain Ωt occupied by the
tumor is described by means of a given velocity V (t, x), where t ≥ 0 and
x ∈ R3. More precisely, assuming V is regular, we solve the associated
system of differential equations
d
dt
X(t, x) = V (t,X(t, x)), t > 0, X(0, x) = x,
and set {
Ωτ = X(τ,Ω0), where Ω0 ⊂ R3 is a given domain,
Γτ = ∂Ωτ , and Qτ = {(t, x)|t ∈ (0, τ), x ∈ Ωτ} .
Moreover, we assume that
divx V (τ, ·) = 0, (1.12)
which by the transport theorem yields
|Ωτ | = |Ω0| for any τ ≥ 0.
The model is closed by giving boundary conditions on the (moving) tumor
boundary Γτ . More precisely, we assume that the boundary Γτ is imperme-
able, meaning
(v − V ) · n|Γτ = 0, for any τ ≥ 0. (1.13)
In addition, for viscous fluids, Navier proposed the boundary condition of
the form
[Sn]tan|Γτ = 0, (1.14)
with S denoting the viscous stress tensor which in this context is assumed
to be determined through Newton’s rheological law
S = µ
(
∇v +∇⊥v − 2
3
div vI
)
+ ξ div vI,
where µ > 0, ξ ≥ 0 are respectively the shear and bulk viscosity coefficients.
Condition (1.14) namely says that the tangential component of the normal
viscous stress vanishes on Γτ .
The concentrations of the nutrient and the drug on the boundary satisfy
the conditions:
C(x, t)|Γt = 0, W (x, t)|Γt = 0. (1.15)
In contrast to the case of avascular tumors where the nutrient typically
diffuses within the tumor region through the boundary, here we assume
that the diffusion of the nutrient occurs through the vessels present in the
area.
Finally, the problem (1.2)-(1.15) is supplemented by the initial conditions{
P (0, ·) = P0, Q(0, ·) = Q0, D(0, ·) = D0,
C(0, ·) = C0 ≤ C¯, W (0, ·) = W0 in Ω0.
(1.16)
The aim of this work is the establishment of the global existence of weak
solutions to the nonlinear system (1.1)-(1.4), (1.8)-(1.9) for finite large initial
data.
Related results on the mathematical analysis of cancer models have been
presented by Zhao [17] based on the framework introduced by Friedman et al.
[8], [9]. The analysis in [8], [9] yields existence and uniqueness of solution to
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a related model in the radial symmetric case for a small time interval [0, T ].
The analysis in [17] treats a parabolic-hyperbolic free boundary problem
and provides a unique global solution in the radially symmetric case. In
[3, 4], Donatelli and Trivisa establish the global existence of weak solutions
to a nonlinear system modeling tumor growth in a general moving domain
Ωt ⊂ R3 without any symmetry assumption and for finite large initial data.
In that context, the nonliner system is governed by transport equations
(1.2)-(1.9) for the evolution of cancerous cells, whereas the evolution of the
velocity field v of the tumor growth is given, by the Brinkman regularization
of the Darcy Law, namely
∇xσ = − µ˜
K
v + µ∆v.
In the present article, we establish the global existence of weak solutions to
the nonlinear system (S)

∇xσ = − µ˜
K
v,
∂P
∂t
+ div(Pv) = GP ,
∂Q
∂t
+ div(Qv) = GQ,
∂D
∂t
+ div(Dv) = GD,
∂C
∂t
= ν1∆C −
(
K1KPCP +K2KQ(C¯ − C)Q
)
C,
∂W
∂t
= ν2∆W − (µ1G1(W )P + µ2G2(W )Q)W.
(S)
on time dependent domains supplemented with the boundary conditions
(1.13), (1.14), (1.15) and the initial data (1.16), by establishing rigorously
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the vanishing viscosity limit µ→ 0 for the following system,
∇xσµ = − µ˜
K
vµ + µ∆vµ,
∂Pµ
∂t
+ div(Pµvµ) = GPµ ,
∂Qµ
∂t
+ div(Qµvµ) = GQµ ,
∂Dµ
∂t
+ div(Dµvµ) = GDµ ,
∂Cµ
∂t
= ν1∆Cµ −
(
K1KPCµPµ +K2KQ(C¯ − Cµ)Qµ
)
Cµ,
∂Wµ
∂t
= ν2∆Wµ − (µ1G1(Wµ)P + µ2G2(Wµ)Qµ)Wµ.
(Sµ)
with the aid of a series of delicate estimates that enable us to treat the van-
ishing viscosity limit within the time-dependent kinematic boundary. The
global existence of weak solutions to (S) is established for general solutions,
that is no symmetry assumption is required and for large initial data.
1.4. General strategy. The main ingredients of our strategy can be for-
mulated as follows:
• Starting from the nonlinear system (Sµ) the procedure, outlined in Sec-
tion 2 below, provides a global weak solution
{Pµ, Qµ, Dµ,vµ, Cµ,Wµ}.
The next step of the investigation involves the derivation of delicate
a priori bounds (uniform in µ) within the time dependent kinematic
boundary. In this part, the condition (1.12) imposed on the boundary
behavior is critical.
• The uniform bounds in µ will allow us to establish the necessary com-
pactness in order to pass into the limit µ → 0 obtaining the global
existence of the solutions of the original problem (S). An important
tool in the analysis is the use of the extension operator for Sobolev
spaces, E : W 1,2(Ωτ ) −→ W 1,2(R3), which is uniformly bounded with
respect to t ∈ [0, T ]. This operator allow us to deal with the moving do-
main Ωτ in the following sense: since the limiting process takes place in
a moving domain Ωτ it will be easier to perform the limit, if we extend
vµ, Cµ and Wµ, Pµ, Qµ, Dµ on the whole domain R3 by setting them
equal to zero outside the tumor domain. Then, since the domain Ωτ is
regular at each time the extension operator E : W 1,2(Ωτ ) −→W 1,2(R3)
can be of use.
1.5. Outline. The paper is organized as follows: Section 1 presents the
motivation, modeling and introduces the necessary preliminary material.
Section 2 provides weak formulation of the problem (S) and states the main
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result. Section 3 presents an outline of the global existence of weak solutions
of the nonlinear system (Sµ). In Section 4 we present delicate a priori
bounds which yield the necessary compactness that is needed in order to
perform rigorously the singular limit. In Section 5 the rigorous limit µ→ 0
is established and we complete the proof of our Main Theorem 2.2.
2. Weak formulation and main results
In this section we present the notion of weak solutions to the nonlinear
system (S).
2.1. Weak solutions.
Definition 2.1. We say that (P,Q,D,v, C,W ) is a weak solution of prob-
lem (S) supplemented with boundary data satisfying (1.13)-(1.15) and initial
data (P0, Q0, D0, C0,W0) satisfying (1.16) provided that the following hold:
• (P,Q,D) ≥ 0 represents a weak solution of (1.2)-(1.3)-(1.4) on (0,∞)×
Ωτ , i.e., for any test function ϕ ∈ C∞c (([0, T ) × R3), T > 0 the following
integral relations hold
∫
Ωτ
Pϕ(τ, ·) dx−
∫
Ω0
P0ϕ(0, ·)dx =∫ τ
0
∫
Ωt
(P∂tϕ+ Pv · ∇xϕ+GPϕ(t, ·)) dxdt,
∫
Ωτ
Qϕ(τ, ·) dx−
∫
Ω0
Q0ϕ(0, ·)dx =∫ τ
0
∫
Ωt
(Q∂tϕ+ Pv · ∇xϕ+GQϕ(t, ·)) dxdt,
∫
Ωτ
Dϕ(τ, ·) dx−
∫
Ω0
D0ϕ(0, ·)dx =∫ τ
0
∫
Ωt
(D∂tϕ+Dv · ∇xϕ+GDϕ(t, ·)) dxdt.

(2.1)
In particular,
P ∈ Lp([0, T ]; Ωτ ), Q ∈ Lp([0, T ]; Ωτ ), D ∈ Lp([0, T ]; Ωτ ) for all p ≥ 1.
We remark that in the weak formulation, it is convenient that the equa-
tions (1.2)-(1.4) hold in the whole space R3 provided that the densities
(P,Q,D) are extended to be zero outside the tumor domain.
• Darcy’s equation (1.1) holds in the sense of distributions, i.e., for any
test function ϕ ∈ C∞c (R3;R3) satisfying
ϕ · n|Γτ = 0 for any τ ∈ [0, T ],
the following integral relation holds∫
Ωτ
σ divϕ dx− µ˜
K
vϕdx = 0. (2.2)
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All quantities in (2.2) are required to be integrable, so in particular,
v ∈W 1,2(R3;R3),
and
(v− V ) · n(τ, ·)|Γτ = 0 for a.a. τ ∈ [0, T ].
• C ≥ 0 is a weak solution of (1.8), i.e., for any test function ϕ ∈
C∞c ([0, T )× R3), T > 0 the following integral relations hold∫
Ωτ
Cϕ(τ, ·) dx−
∫
Ω0
C0ϕ(0, ·)dx =
∫ τ
0
∫
Ωt
C∂tϕdxdt−∫ τ
0
∫
Ωt
ν1∇xC · ∇xϕdxdt−
∫ τ
0
∫
Ωt
(
K1KPCP +K2KQ(C¯ − C)Q
)
Cϕdxdt.
• W ≥ 0 is a weak solution of (1.9), i.e., for any test function ϕ ∈
C∞c ([0, T )× R3), T > 0 the following integral relations hold∫
Ωτ
Wϕ(τ, ·) dx−
∫
Ω0
W0ϕ(0, ·)dx =
∫ τ
0
∫
Ωt
W∂tϕdxdt−∫ τ
0
∫
Ωt
ν2∇xW · ∇xϕdxdt−
∫ τ
0
∫
Ωt
(µ1G1(W )P + µ2G2(W )Q)Wdxdt.
The main result of the article now follows.
Theorem 2.2. Let Ω0 ⊂ R3 be a bounded domain of class C2+ν . Assume
that the vector field V belongs to the class
V ∈ C1([0, T ];C3c (R3;R3)), divx V (τ, ·) = 0 for all τ ∈ [0, T ].
Let the initial data satisfy
P0 ∈ Lp(R3), Q0 ∈ Lp(R3), D0 ∈ Lp(R3), for all p ≥ 1
and
C0 ∈ L2(R3) ∩ L∞(R3), W0 ∈ L2(R3) ∩ L∞(R3),
with (P0, Q0, D0, C0,W0) ≥ 0, (P0, Q0, D0, C0,W0) 6≡ 0,
P0 +Q0 +D0 = %f , (P0, Q0, D0, C0,W0)|R3\Ω0 = 0.
Then the problem (S) with initial data (1.16) and boundary data (1.13)-
(1.15) admits a weak solution in the sense specified in Definition 2.1.
3. Global Existence of Weak Solutions to the system Sµ
As already said in Section 1, we will prove the Theorem 2.2 by performing
the vanishing viscosity limit of the system (Sµ). Therefore we consider the
system (Sµ) endowed with the following initial data{
Pµ(0, ·) = Pµ0 = P0, Qµ(0, ·) = Qµ0 = Q0, Dµ(0, ·) = Dµ0 = D0,
Cµ(0, ·) = Cµ0 = C0 ≤ C¯, Wµ(0, ·) = Wµ0 = W0 in Ω0.
(3.1)
and the following boundary data:
(vµ − V ) · n|Γτ = 0, for any τ ≥ 0. (3.2)
[Sn]tan|Γτ = 0, (3.3)
Cµ(x, t)|Γt = 0, Wµ(x, t)|Γt = 0. (3.4)
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In this section, we discuss briefly for completeness the global existence of
weak solutions to the nonlinear system (Sµ) presented in [4]. The following
result established in [4] will be essential in the sequel.
Theorem 3.1. Let Ω0 ⊂ R3 be a bounded domain of class C2+ν and let
V ∈ C1([0, T ];C3c (R3;R3))
be given. Let the initial data satisfy
Pµ0 ∈ Lp(R3), Qµ0 ∈ Lp(R3), Dµ0 ∈ Lp(R3), for all p ≥ 1
and
Cµ0 ∈ L2(R3) ∩ L∞(R3), Wµ0 ∈ L2(R3) ∩ L∞(R3),
with (Pµ0, Qµ0, Dµ0, Cµ0,Wµ0) ≥ 0, (Pµ0, Qµ0, Dµ0, Cµ0,Wµ0) 6≡ 0,
Pµ0 +Qµ0 +Dµ0 = %f , (Pµ0, Qµ0, Dµ0, Cµ0,Wµ0)|R3\Ω0 = 0.
Then the problem (Sµ) with initial data (3.1) and boundary data (3.2)-(3.4)
admits a weak solution satisfying the constraint
Pµ +Qµ +Dµ = %f (3.5)
Proof. We present here the main ingredients of the proof of the Theorem
3.1 presented in [4] (in order to simplify the notations we drop the index µ).
• Our approach involves the construction of a suitable approximating
scheme which relies on the penalization of the boundary behavior, diffu-
sion and viscosity in the weak formulation. The approximating scheme
employs the variables ε (for the penalization of the boundary behavior)
and ω (for the penalization of the diffusion and viscosity).
a. In the center of the approach lie the so-called generalized penalty
methods typically suitable for treating partial slip, free surface,
contact and related boundary conditions in viscous flow analysis
and simulations. This form of boundary penalty approximation
appeared by Courant in [2], in the context of slip conditions for
stationary incompressible fluids by Stokes and Carrey in [14], and
more recently in a series of articles (cf. [3], [5], [4],[6], [7]).
More specifically, the boundary condition (1.13) is treated as a
weakly enforced constraint, in the sense that the variational (weak)
formulation of the Brinkman equation is supplemented by a singu-
lar forcing term
1
ε
∫
Γt
(v − V ) · nϕ · ndSx, ε > 0 small,
penalizing the normal component of the velocity on the boundary
of the tumor domain.
b. A variable shear viscosity coefficient µ = µω, as well as a variable
diffusions νi = νiω, i = 1, 2 with µω, νiω are introduced, with the
property that they vanish outside the tumor domain and remain
positive within the tumor domain. The addition, of the variable ω
allows us the treat the moving domain.
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• Keeping ε and ω fixed, we solve the modified problem in a (bounded)
reference domain B ⊂ R3 chosen in such way that
Ω¯τ ⊂ B for any τ ≥ 0
with the aid of a Faedo-Galerkin approximation. We refer the reader
to [4] for the details. The solution {Pω,ε, Qω,ε, Dω,ε,vω,ε} constructed
satisfy the following uniform bounds:
0 ≤ Pω,ε, Qω,ε, Dω,ε ≤ %f in [0, T ]×B, (3.6)
this entails that for any p ≥ 1
Pω,ε, Qω,ε, Dω,ε are uniformly bounded in L
p([0, T ]×B). (3.7)
Moreover we have the following uniform bounds for nutrient Cω,ε, the
drug concentration Wω,ε the velocity vω,ε and the pressure σω,ε
Cω,ε(x, t) ∈ L∞([0, T ]×B). (3.8)
Wω,ε(x, t) ∈ L∞([0, T ]×B). (3.9)
‖Cω,ε‖L2tL2x + ‖ν1ω∇xCω,ε‖L2tL2x ≤ c, (3.10)
‖Wω,ε‖L2tL2x + ‖ν2ω∇xWω,ε‖L2tL2x ≤ c, (3.11)
where LqtL
p
x stands for Lq(0, T ;L2(B)). In addition,
‖σω,ε‖Lβx ≤ c, 1 < β ≤ 2 (3.12)
‖µωvω,ε‖L2x + ‖µω∇xvω,ε‖L2x ≤ c, (3.13)
∫
Γt
|(vω,ε − V ) · n|2dS ≤ cε. (3.14)
• Letting the penalization ε→ 0 for fixed ω > 0 we obtain a “two-phase”
model consisting of the tumor region and the healthy tissue separated
by impermeable boundary. We show that the densities vanish in part of
the reference domain, specifically on ((0, T )×B) \QT . The main issue
is to describe the evolution of the interface Γτ . To that effect we employ
elements from the so-called level set method.
• The final result is obtained by performing the limit ω → 0.

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4. A Priori Estimates
In this section we collect all the a priori estimates uniform in µ satisfied
by the solutions of the system (Sµ). Let us mention that, in the sequel, we
will denote by c any constant that depends on %f , C¯, W¯ , the initial data
(1.16) and the boundary conditions (1.14)-(1.15). First of all we observe
that because of the condition (3.5) we get that
0 ≤ Pµ, Qµ, Dµ ≤ %f in [0, T ]× Ωτ , (4.1)
from which it follows that for any p ≥ 1
Pµ, Qµ, Dµ are uniformly bounded in L
p([0, T ]× Ωτ ). (4.2)
By a standard application of the maximum principle to the parabolic equa-
tions satisfied by the nutrient Cµ and the drug concentration Wµ we have
that
sup
t∈[0,T ]
‖Cµ‖L∞(Ωt) ≤ C¯, sup
t∈[0,T ]
‖Wµ‖L∞(Ωt) ≤ W¯ (4.3)
Now, by multiplying (1.8) by Cµ, by integrating by parts and by taking
into account (4.1), (4.2), (4.3) we get that Cµ satisfies the following energy
estimate,∫
Ωτ
1
2
|Cµ|2dx+ ν1
∫ τ
0
∫
Ωt
|∇xCµ|2dxdt
≤ c
∫
Ωτ
|C0|2dx+
∫ τ
0
∫
Ωt
|Cµ|2dxdt,
(4.4)
similarly, taking into account that G1 and G2 are smooth functions we have
also ∫
Ωτ
1
2
|Wµ|2dx+ ν2
∫ τ
0
∫
Ωt
|∇xWµ|2dxdt
≤ c
∫
Ωτ
|W0|2dx+
∫ τ
0
∫
Ωt
|Wµ|2dxdt,
(4.5)
As a consequence of (4.4) and (4.5) we get the following uniform bounds∫ T
0
‖Cµ‖2W 1,2(Ωt)dt ≤ c,
∫ T
0
‖Wµ‖2W 1,2(Ωt)dt ≤ c. (4.6)
Now we focus our attention on the velocity field vµ. First we notice that by
adding up the equations (Sµ)2 − (Sµ)4 we have
ρf div vµ = KBCµPµ −KRDµ = G, (4.7)
where by using (4.2) we have that G ∈ Lp(Ωτ ), p ≥ 1. Next, by applying
regularity theory concerning the divergence equation in Sobolev spaces (see
Lemma 2.1.1 (a) in [13] or Remark 3.19 in [10], for more details see also [3])
we end up with
‖∇xvµ‖Lpx ≤ c‖G‖Lpx , p > 1. (4.8)
On the other hand by considering the equation (Sµ)1, by taking into account
(4.7) and (4.8) and by a standard application of elliptic regularity theory
(see again [3]) we conclude with the following uniform bound with respect
to µ,
‖σµ‖L2x ≤ c. (4.9)
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Now, by using (4.7), (4.9) and by multiplying the equation (Sµ)1 by vµ and
by integrating by parts we have
µ˜
K
∫
Ωτ
|vµ|2dx+ µ
∫
Ωτ
|∇xvµ|2dx ≤ c. (4.10)
We remark that the soleindal condition (1.12) on V was essential in order
to get the estimates (4.4), (4.5), (4.10).
5. Vanishing viscosity limit µ→ 0
In this section we perform the limit µ→ 0 in order to recover the system
(S). Since our limiting process takes place in a moving domain Ωτ it is more
convenient to extend vµ, Cµ and Wµ, Pµ, Qµ, Dµ on the whole domain R3
by setting them equal to zero outside the tumor domain. In fact in this way
one performs the limiti in a “time independent domain”. Then, since the
domain Ωτ is regular at each time we use the standard extension operator
for Sobolev spaces, E : W 1,2(Ωτ ) −→ W 1,2(R3), uniformely bounded with
respect to t ∈ [0, T ], (for details on the operator E see [1]).
From the uniform bounds (4.6), (4.10) we get
ECµ −→ C weakly in L2(0, T ;W 1,2(R3)), (5.1)
EWµ −→W weakly in L2(0, T ;W 1,2(R3)), (5.2)
Evµ −→ v weakly in W 1,2(R3). (5.3)
By taking into account (4.2) and (4.10) we have we get
Pµvµ → Pv
Qµvµ → Qv
Dµvµ → Dv
 weakly-(∗) in L
∞(T1, T2;L2q/q+2(K)), 2 ≤ q < 6, . (5.4)
where K ⊂ Ωτ is a compact subset. Moreover, from the equations (Sµ)2 −
(Sµ)4 it follows that
Pµvµ → Pv
Qµvµ → Qv
Dµvµ → Dv
 in Cweak([T1, T2];L
2q/q+2(K)), 2 ≤ q < 6. (5.5)
Now, by using (4.2), (4.6), as before we get also
PµCµ → PC
QµCµ → QC
DµCµ → DC
PµWµ → PW
QµWµ → QW

weakly-(∗) in L∞(0, T ;L2q/q+2(K)), 2 ≤ q < 6. (5.6)
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Remark 5.1. Since the compact set K can be chosen arbitrarily close to the
the boundary of QT , the above convergences (5.4), (5.5), (5.6) take place in
the whole cylinder QT .
Now, by standard computations, and by taking into account (4.10) we
have
√
µ
∫
Ωτ
√
µ∇xvω : ∇xϕdx −→ 0 as µ→ 0.
At this point it is straightforward to pass into the limit in the weak for-
mulations of the system (Sµ) and to conclude the proof of the Theorem
2.2.
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